参考文献/References:
[1] 高社干,魏洛霞,王立东,等.肿瘤光动力治疗的研究现状与展望.郑州大学学报:医学版,2008,43(3):405-411.
[2] 谢松梅,符世平.光动力治疗药物光敏剂的治疗学特点及临床评价要素.中国新药杂志,2008,17(7):618-620.
[3] 卢晓珣,郭坤元.光动力治疗药物5-氨基乙酰丙酸及其己脂的相关研究进展.实用医学杂志,2008,24(12):2035-2037.
[4] 王晶,潘勇华,王旭明,等.光敏剂及其临床应用进展.药学实践杂志,2002,20(2):67.
[5] Ackroyd R,Kehy C, Brown N,et al.The history of photodetection and photodynamic therapy. Photoehem Photobiol, 2001,74(5):656-669.
[6] 毛永平,邱海霞,顾瑛,等.进展期食管癌的光动力治疗.中国激光医学杂志,2010,19(1):10-13.
[7] 苏颖玲.光动力治疗恶性肿瘤的临床观察与护理.护理研究, 2009.23(6):1462-1463.
[8] 商少宏,王淑真,张海萍,等.原发性肝癌光化学疗法的疗效及临床意义.福建医科大学学报,2004,38(4):419-421.
[9] 刘华文,吴敬波.放射增敏机制的研究进展.西南军医,2009,11(2):250-252.
[10] Chen W,Zhang J. Using nanoparticles to enable simultaneous radiation and photodynamic therapies for cancer treatments. J nanosci nanotechnol, 2006, 6(4):1159-1166.
[11] 谢莹,黄光武,黄樱樱,等.纳米技术在光动力治疗恶性肿瘤中的应用前景.中国激光医学杂志,2009,18(1):55-58.
[12] Park YS,Kasuya A,Dmytruk A,et al. Concentrated colloids of silica-encapsulated gold nanoparticles:colloidal stability,cytotoxicity, and X-ray absorption. J Nanosci Nanotechnol, 2007,7(8):2690-2695.
[13] Juzenas P,Chen W,Sun YP,et al. Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer. Adv Drug Deliv Rev, 2008, 60(15):1600-1614.
[14] Park YS,Liz-Marzán LM, Kasuya A, et al. X-ray absorption of gold nanoparticles with thin silica shell. J Nanosei Nanotechnol, 2006,6(11):3503-3506.
[15] Pamujula S, Kishore V, Rider B, et al. Radioprotection in mice following oral delivery of amifostine nanoparticles. Int J Radial Biol, 2005,81(3):251-257.
[16] Reddy JA,Allagadda VM, Leamon CP. Targeting therapeutic and imaging agents to folate receptor positive tumors. Curt Pharm Biotechnol, 2005,6(2):131-150.
[17] 赵杰,曹胜利,郑晓霖,等.叶酸受体介导的抗肿瘤药物研究进展.药学学报,2009(2):109-114.
[18] Bharali DJ,Lucey DW,Jayakumar H,et al. Folate-receptormediated delivery of InP quantum dots for bioimaging using confocal and two-photon microscopy. J Am Chem Soc,2005,127(32):11364-11371.
[19] Kim SH,Jcong JH,Chun KW,et al. Target-specific cellular uptake of PLGA nanoparticles coated with poly (L-lysine)-poly (ethylene glycol)-folate conjugate. Langmuir, 2005, 21(19):8852-8857.
[20] Suresh Reddy J,Venkateswarlu V,Koning GA,et al. Radio-protective effect of transferrin targeted citicoline liposomes. J Drug Target, 2006,14(1):13-19.
[21] Daroczi B,Kari G,McAleer MF,et al. In vivo radioprotection by the fullerene nanoparticle DF-1 as assessed in a zebrafish model. Clin Cancer Res, 2006, 12(23):7086-7091.
[22] 刘应亮,雷炳富,邝金勇,等.长余辉发光材料研究进展.无机化学学报,2009(8):1323-1329.
相似文献/References:
[1]何燕,苏晋,郑晓霞,等.P-糖蛋白抑制剂在PET显像中的应用研究[J].国际放射医学核医学杂志,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
He Yan,Su Jin,ZhengXiaoxia,et al.Developing P-glycoprotein inhibitor marked by PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
[2]许飞,刘建军,黄钢,等.PET乏氧显像在预测肿瘤乏氧及指导临床治疗中的应用进展[J].国际放射医学核医学杂志,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
Xu Fei,Liu Jianjun,Huang Gang,et al.The application of hypoxia imaging with PET in predicting tumor hypoxia and guiding clinical therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
[3]李景涛,邓垒,张文珏,等.广泛期小细胞肺癌胸部IMRT后发生放射性肺炎的危险因素分析[J].国际放射医学核医学杂志,2016,40(2):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
Li Jingtao,Deng Lei,Zhang Wenjue,et al.Risk factor analysis for predicting radiation pneumonitis in extensive stage small cell lung cancer patients receiving IMRT thoracic radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
[4]陈顺军,程兵.肿瘤细胞凋亡核素显像分子探针研究进展[J].国际放射医学核医学杂志,2016,40(2):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
Chen Shunjun,Cheng Bing.Progress in molecular probes of radionuclide tumor apoptosis imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
[5]刘佳,高刚,朴春南,等.调节肿瘤放射敏感性的miRNAs研究进展[J].国际放射医学核医学杂志,2016,40(2):159.[doi:10.3760/cma.j.issn.1673-4114.2016.02.015]
Liu Jia,Gao Gang,Piao Chunnan,et al.Progress of microRNAs in regulating tumor radiation sensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):159.[doi:10.3760/cma.j.issn.1673-4114.2016.02.015]
[6]赵德云,李百龙.植物提取物防治放射性肺损伤的现状与展望[J].国际放射医学核医学杂志,2016,40(3):208.[doi:10.3760/cma.j.issn.1673-4114.2016.03.010]
Zhao Deyun,Li Bailong.Protective and therapeutic effects of plant extracts on radiation-induced lung injury:present status and future prospects[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):208.[doi:10.3760/cma.j.issn.1673-4114.2016.03.010]
[7]田琦,蒋宁一,郑丽.265例精细个体化131I治疗Graves甲亢的疗效观察[J].国际放射医学核医学杂志,2016,40(4):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
Tian Qi,Jiang Ningyi,Zheng Li.Therapeutic effect of fine individual 131I treatment on Graves disease hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
[8]邓大平,卢峰,孙洪强,等.颅脑肿瘤放射治疗时射野外器官吸收剂量体模法测量与分析[J].国际放射医学核医学杂志,2016,40(4):272.[doi:10.3760/cma.j.issn.1673-4114.2016.04.007]
Deng Daping,Lu Feng,Sun Hongqiang,et al.Test and analysis of out-of-field organ dose in intracranial tumor radiotherapy using phantom[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):272.[doi:10.3760/cma.j.issn.1673-4114.2016.04.007]
[9]任佳忠,李永梅,刘岩,等.99Tcm-MDP骨显像胸部异常放射性摄取的原因分析[J].国际放射医学核医学杂志,2016,40(6):459.[doi:10.3760/cma.j.issn.1673-4114.2016.06.011]
Jiazhong,Li Yongmei,Liu Yan,et al.Reasons for the abnormal 99Tcm-MDP uptake in the thoracic tissue on bone scintigraphy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):459.[doi:10.3760/cma.j.issn.1673-4114.2016.06.011]
[10]马彦云,张辉.磁共振体素内不相干运动扩散加权成像的原理及应用进展[J].国际放射医学核医学杂志,2016,40(6):469.[doi:10.3760/cma.j.issn.1673-4114.2016.06.013]
Ma Yanyun,Zhang Hui.The basic principle and application progress of intravoxel incoherent motion imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):469.[doi:10.3760/cma.j.issn.1673-4114.2016.06.013]
[11]陈晓艳,张江虹,邵春林.STAT3与辐射敏感相关性的研究进展[J].国际放射医学核医学杂志,2016,40(3):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
Chen Xiaoyan,Jianghong,Shao Chunlin.Research progresses of correlation between STAT3 and radiosensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
[12]赵舒怡,储小飞,樊赛军.血清肿瘤标志物与肿瘤放疗疗效评估的研究进展[J].国际放射医学核医学杂志,2015,39(5):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
zhao shuyi,chu xiaofei,fan saijun..progression of study on serum tumor markers in evaluation of tumor radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
[13]赵徵鑫,翟贺争,张文艺,等.质子重离子治疗肿瘤的进展[J].国际放射医学核医学杂志,2016,40(5):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
Zhao Zhixin,Zhai Hezheng,Zhang Wenyi,et al.Development of proton heavy ion in tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
[14]贾立立,孟粹达,刘晓冬,等.头颈部肿瘤放疗中转化医学相关机制的研究进展[J].国际放射医学核医学杂志,2015,39(3):247.[doi:10.3760/cma.j.issn.1673-4114.2015.03.013]
Jia Lili,Meng Cuida,Liu Xiaodong,et al.Development in translational medicine-related mechanisms of radiotherapy for head and neck cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):247.[doi:10.3760/cma.j.issn.1673-4114.2015.03.013]
[15]章鹤,宋建元,曹建平.肿瘤放射增敏药物的研究进展[J].国际放射医学核医学杂志,2014,38(6):408.[doi:10.3760/cma.j.issn.1673-4114.2014.06.014]
Zhang He,Song Jian-yuan,Cao Jian-ping.The research progression of cancer radio-sensitization drugs[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(5):408.[doi:10.3760/cma.j.issn.1673-4114.2014.06.014]
[16]李继涛,何明远,袁德晓,等.p53调控的能量代谢对辐射效应的影响[J].国际放射医学核医学杂志,2012,36(6):380.[doi:10.3760/cma.j.issn.1673-4114.2012.06.014]
LI Ji-tao,HE Ming-yuan,YUAN De-xiao,et al.Influence of p53-regulated energy metabolism in radiation effects[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(5):380.[doi:10.3760/cma.j.issn.1673-4114.2012.06.014]
[17]万丹丹,王宏,温镭,等.放射治疗热增敏作用研究进展[J].国际放射医学核医学杂志,2012,36(3):160.[doi:10.3760/cma.j.issn.1673-4114.2012.03.010]
WAN Dan-dan,WANG Hong,WEN Lei,et al.Progress on thermal sensitization of radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(5):160.[doi:10.3760/cma.j.issn.1673-4114.2012.03.010]
[18]何垠波,周莉,徐庆丰,等.网络管理对肿瘤放疗流程的优化[J].国际放射医学核医学杂志,2012,36(3):182.[doi:10.3760/cma.j.issn.1673-4114.2012.03.016]
HE Yin-bo,ZHOU Li,XU Qing-feng,et al.Optimization of the radiotherapy procedure using network management[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(5):182.[doi:10.3760/cma.j.issn.1673-4114.2012.03.016]
[19]郭睿,李彪.早期生长反应基因1启动子介导肿瘤基因-放疗的研究进展[J].国际放射医学核医学杂志,2010,34(4):206.[doi:10.3760/cma.j.issn.1673-4114.2010.04.004]
GUO Rui,LI Biao.The progress of tumor gene-radiotherapy induced by Egr-1 promoter[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(5):206.[doi:10.3760/cma.j.issn.1673-4114.2010.04.004]
[20]宋建波,李思进.放射性心脏损伤临床研究进展[J].国际放射医学核医学杂志,2011,35(2):117.[doi:10.3760/cma.j.issn.1673-4114.2011.02.013]
SONG Jian-bo,LI Si-jin.Advance in clinical research of radiation-induced heart disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(5):117.[doi:10.3760/cma.j.issn.1673-4114.2011.02.013]